Eminence Capital’s Zimmer Biomet ZBH Stock Holding History

Eminence Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-166,923	Closed	-$23.7M	–	80
2021 Q3	$23.7M	Buy	+166,923	New	+$24.6M	0.32%	57
2015 Q2	–	Sell	-778,503	Closed	-$88.8M	–	69
2015 Q1	$88.8M	Sell	778,503 -278,182	-26%	-$31.7M	1.38%	35
2014 Q4	$116M	Buy	1,056,685 +294,485	+39%	+$31M	1.69%	26
2014 Q3	$74.4M	Buy	+762,200	New	+$75M	1.09%	49

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Eminence Capital's ZBH Position: Q4 2021 in Review

Eminence Capital sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 166,923 shares — an estimated $23.7M sold.

Eminence Capital first reported a position in ZBH in Q3 2014 and held it in 4 quarters. The position peaked at $116M in Q4 2014. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

Eminence Capital reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
Eminence Capital sold 166,923 Zimmer Biomet shares in Q4 2021, an estimated $23.7M.
Eminence Capital first reported a position in Zimmer Biomet in Q3 2014 and held it in 4 quarters.
Eminence Capital's Zimmer Biomet position peaked at $116M in Q4 2014.
998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Eminence Capital's 13F filing for Q4 2021, filed 14 Feb 2022.